Evidence map›Paper›PMID 26057873›Full record

ArticleDNA and cell biology2015

ApoM Suppresses TNF-α-Induced Expression of ICAM-1 and VCAM-1 Through Inhibiting the Activity of NF-κB.

Ji-Juan Gao, Yan-Wei Hu, Yan-Chao Wang, Yan-Hua Sha, Xin Ma, Shu-Fen Li, Jia-Yi Zhao, Jing-Bo Lu, Chuan Huang, Jing-Jing Zhao and 2 more

Abstract read
In one paragraph

Article in DNA and cell biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 21 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Evaluation of the anti-gout effect ofMedicine and pharmacy reports · 2021
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Ji-Juan Gao1 Laboratory Medicine Center, Nanfang Hospital, Southern Medical University , Guangzhou, China .
Yan-Wei Hu1 Laboratory Medicine Center, Nanfang Hospital, Southern Medical University , Guangzhou, China .
Yan-Chao Wang1 Laboratory Medicine Center, Nanfang Hospital, Southern Medical University , Guangzhou, China .
Yan-Hua Sha1 Laboratory Medicine Center, Nanfang Hospital, Southern Medical University , Guangzhou, China .
Xin Ma2 Department of Anesthesiology, Nanfang Hospital, Southern Medical University , Guangzhou, China .
Shu-Fen Li1 Laboratory Medicine Center, Nanfang Hospital, Southern Medical University , Guangzhou, China .
Jia-Yi Zhao1 Laboratory Medicine Center, Nanfang Hospital, Southern Medical University , Guangzhou, China .
Jing-Bo Lu3 Department of Vascular Surgery, Nanfang Hospital, Southern Medical University , Guangzhou, China .
Chuan Huang1 Laboratory Medicine Center, Nanfang Hospital, Southern Medical University , Guangzhou, China .
Jing-Jing Zhao1 Laboratory Medicine Center, Nanfang Hospital, Southern Medical University , Guangzhou, China .
Lei Zheng1 Laboratory Medicine Center, Nanfang Hospital, Southern Medical University , Guangzhou, China .
Qian Wang1 Laboratory Medicine Center, Nanfang Hospital, Southern Medical University , Guangzhou, China .
Nanfang Hospital · CNSouthern Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To explore the anti-inflammatory effect of apolipoprotein M (apoM) on regulation of tumor necrosis factor-α (TNF-α)-induced expression of intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) and further investigate the molecular mechanism of apoM in this process. We found that TNF-α could decrease expression of apoM and inhibitor of NF-κB-α (IκBα) in HepG2 cells. Overexpression of apoM caused a significant decrease of ICAM-1 and VCAM-1 expression, while it caused a significant increase of IκBα expression in HepG2 cells. Furthermore, the treatment with TNF-α could increase ICAM-1 and VCAM-1 expression, decrease IκBα protein expression, and increase nuclear factor-κB (NF-κB) activity, and these effects were markedly enhanced by small interfering RNA (siRNA)-mediated silencing of apoM in HepG2 cells. Our findings demonstrated that apoM suppressed TNF-α-induced expression of ICAM-1 and VCAM-1 through inhibiting the activity of NF-κB.

Indexed as

ApolipoproteinsApolipoproteins MDown-RegulationGene Expression RegulationHep G2 CellsHumansIntercellular Adhesion Molecule-1LipocalinsNF-kappa BSignal TransductionTumor Necrosis Factor-alphaVascular Cell Adhesion Molecule-1ApolipoproteinsApolipoproteins MAPOM protein, humanIntercellular Adhesion Molecule-1LipocalinsNF-kappa BTumor Necrosis Factor-alphaVascular Cell Adhesion Molecule-1

Identifiers

PMID26057873
PMCPMC4522953
OpenAlexW2120903784

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.